{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:01:26Z","timestamp":1787918486239,"version":"build-2784847793"},"reference-count":91,"publisher":"Oxford University Press (OUP)","issue":"58","license":[{"start":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T00:00:00Z","timestamp":1637971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,28]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Session 2 of the National Cancer Institute\u2019s Cannabis, Cannabinoids, and Cancer Research Workshop opened with testimony from a lymphoma survivor who detailed medicinal cannabis-related improvements in nausea, low appetite, insomnia, and mental health and the limited clinical counsel she received regarding cannabis use. Discussion next turned to the evolution of the legal landscape of cannabis in the United States, one in which state and federal laws frequently conflict and the Controlled Substance Act renders cannabis Schedule I. This legal climate creates conundrums for US medicinal cannabis researchers who contend with limited funding opportunities, avenues to source trial drug, and procedural red tape and for oncology clinicians who recommend medicinal cannabis to patients with some frequency while perceiving themselves as ill equipped to make such clinical recommendations. Ultimately, it creates challenges for cancer patients who find themselves turning to nonmedical and anecdotal information sources. The risks of cannabis use by the cancer patient were discussed next. These include infection, pharmacodynamic and pharmacokinetic drug-botanical interactions, cyclic nausea and vomiting, e-cigarette or vaping product use\u2013associated illness, legal issues, and high cost. The session concluded with a broad survey of the research supporting oncologic cannabinoid use, conclusive evidence for chemotherapy-induced nausea and vomiting, and suggestive evidence for cancer-related pain.<\/jats:p>","DOI":"10.1093\/jncimonographs\/lgab012","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T11:24:37Z","timestamp":1631100277000},"page":"68-77","source":"Crossref","is-referenced-by-count":11,"title":["Cannabis and the Cancer Patient"],"prefix":"10.1093","volume":"2021","author":[{"given":"Ilana M","family":"Braun","sequence":"first","affiliation":[{"name":"Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, USA"},{"name":"Department of Psychiatry, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald I","family":"Abrams","sequence":"additional","affiliation":[{"name":"Department of Medicine, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey E","family":"Blansky","sequence":"additional","affiliation":[{"name":"School of Industrial and Labor Relations, Cornell University, Ithaca, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A","family":"Pergam","sequence":"additional","affiliation":[{"name":"University of Washington School of Medicine, Seattle, WA, USA"},{"name":"Fred Hutchinson Cancer Research Center, Seattle, WA, USA"},{"name":"Seattle Cancer Care Alliance, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,11,27]]},"reference":[{"issue":"1","key":"2021120111525606400_lgab012-B1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/cncr.33202","article-title":"Cancer patients\u2019 experiences with medicinal cannabis-related care","volume":"127","author":"Braun","year":"2020","journal-title":"Cancer"},{"issue":"3","key":"2021120111525606400_lgab012-B2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5055\/jom.2009.0016","article-title":"Medicinal use of cannabis in the United States: historical perspectives, current trends, and future directions","volume":"5","author":"Aggarwal","year":"2009","journal-title":"J Opioid Manag"},{"issue":"3","key":"2021120111525606400_lgab012-B3","first-page":"180","article-title":"Medicinal cannabis: history, pharmacology, and implications for the acute care setting","volume":"42","author":"Bridgeman","year":"2017","journal-title":"PT"},{"key":"2021120111525606400_lgab012-B4","doi-asserted-by":"crossref","DOI":"10.5040\/9798400678158","volume-title":"Legalizing Marijuana: Drug Policy Reform and Prohibition Politics","author":"Gerber","year":"2004"},{"key":"2021120111525606400_lgab012-B5"},{"key":"2021120111525606400_lgab012-B6","author":"Miller","year":"2017"},{"key":"2021120111525606400_lgab012-B7"},{"key":"2021120111525606400_lgab012-B8","author":"Gurman"},{"key":"2021120111525606400_lgab012-B9"},{"key":"2021120111525606400_lgab012-B10"},{"key":"2021120111525606400_lgab012-B11"},{"key":"2021120111525606400_lgab012-B12","volume-title":"The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research","year":"2017"},{"key":"2021120111525606400_lgab012-B13","year":"2021"},{"issue":"9","key":"2021120111525606400_lgab012-B14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.7326\/M18-1883","article-title":"Reconciling the discrepancies in medicine\u2019s relationship to medical marijuana","volume":"169","author":"Braun","year":"2018","journal-title":"Ann InternMed"},{"issue":"22","key":"2021120111525606400_lgab012-B15","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1002\/cncr.30879","article-title":"Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use","volume":"123","author":"Pergam","year":"2017","journal-title":"Cancer"},{"issue":"19","key":"2021120111525606400_lgab012-B16","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1200\/JCO.2017.76.1221","article-title":"Medical oncologists\u2019 beliefs, practices and knowledge regarding marijuana used therapeutically: a nationally-representative survey study","volume":"36","author":"Braun","year":"2018","journal-title":"J Clin Oncol"},{"key":"2021120111525606400_lgab012-B17","author":"Fann","year":"2018"},{"issue":"2","key":"2021120111525606400_lgab012-B18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ccm.2016.12.006","article-title":"Fungal pneumonias in patients with hematologic malignancies and those undergoing hematopoietic cell transplantation","volume":"38","author":"Pergam","year":"2017","journal-title":"Clin Chest Med"},{"issue":"6","key":"2021120111525606400_lgab012-B19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/QCO.0000000000000502","article-title":"Invasive fungal disease and cytomegalovirus infection: is there an association?","volume":"31","author":"Yong","year":"2018","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"2021120111525606400_lgab012-B20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12281-019-00343-9","article-title":"Fungal infections with ibrutinib and other small- molecule kinase inhibitors","volume":"13","author":"Zarakas","year":"2019","journal-title":"Curr Fungal Infect Rep"},{"issue":"22","key":"2021120111525606400_lgab012-B21","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1001\/jama.284.22.2869","article-title":"Fungal contamination of tobacco and marijuana","volume":"284","author":"Verweij","year":"2000","journal-title":"JAMA"},{"issue":"8","key":"2021120111525606400_lgab012-B22","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1056\/NEJM198102193040812","article-title":"Aspergillus: an inhalable contaminant of marihuana","volume":"304","author":"Kagen","year":"1981","journal-title":"N Engl J Med"},{"issue":"24","key":"2021120111525606400_lgab012-B23","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1056\/NEJM198206173062424","article-title":"Do water pipes prevent transmission of fungi from contaminated marijuana?","volume":"306","author":"Moody","year":"1982","journal-title":"N Engl J Med"},{"key":"2021120111525606400_lgab012-B24","first-page":"176","article-title":"Pulmonary mucormycosis associated with medical marijuana use","volume":"26","author":"Stone","year":"2019","journal-title":"Respir Med Case Rep"},{"issue":"6","key":"2021120111525606400_lgab012-B25","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3201\/eid2606.191570","article-title":"Cannabis use and fungal infections in a commercially insured population, United States, 2016","volume":"26","author":"Benedict","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"2021120111525606400_lgab012-B26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles?","volume":"62","author":"Verweij","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2021120111525606400_lgab012-B27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12275-015-5014-7","article-title":"The molecular mechanism of azole resistance in Aspergillus fumigatus: from bedside to bench and back","volume":"53","author":"Wei","year":"2015","journal-title":"J Microbiol"},{"issue":"6","key":"2021120111525606400_lgab012-B28","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/myc.12324","article-title":"Multi-triazole-resistant Aspergillus fumigatus infections in Australia","volume":"58","author":"Kidd","year":"2015","journal-title":"Mycoses"},{"issue":"12","key":"2021120111525606400_lgab012-B29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"2021120111525606400_lgab012-B30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1039\/C3AY40930A","article-title":"Detection of pesticides in seized illegal cannabis plants","volume":"6","author":"Schneider","year":"2014","journal-title":"Anal Methods"},{"key":"2021120111525606400_lgab012-B31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.forsciint.2017.05.016","article-title":"The use of pesticides in Belgian illicit indoor cannabis plantations","volume":"277","author":"Cuypers","year":"2017","journal-title":"Forensic Sci Int"},{"issue":"3","key":"2021120111525606400_lgab012-B32","first-page":"589","article-title":"Contamination of marihuana cigarettes with pathogenic bacteria--possible source of infection in cancer patients","volume":"66","author":"Ungerleider","year":"1982","journal-title":"Cancer Treat Rep"},{"issue":"21","key":"2021120111525606400_lgab012-B33","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM198205273062101","article-title":"Salmonellosis associated with marijuana: a multistate outbreak traced by plasmid fingerprinting","volume":"306","author":"Taylor","year":"1982","journal-title":"N Engl J Med"},{"issue":"5","key":"2021120111525606400_lgab012-B34","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1164\/ajrccm.156.5.9704146","article-title":"Marijuana and cocaine impair alveolar macrophage function and cytokine production","volume":"156","author":"Baldwin","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"2021120111525606400_lgab012-B35","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.chest.2018.05.005","article-title":"Marijuana and lung disease","volume":"154","author":"Tashkin","year":"2018","journal-title":"Chest"},{"issue":"6 Pt 1","key":"2021120111525606400_lgab012-B36","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1164\/ajrccm.150.6.7952605","article-title":"Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users","volume":"150","author":"Caiaffa","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2021120111525606400_lgab012-B37","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1080\/00952990.2019.1676433","article-title":"The association between regular cannabis use, with and without tobacco co-use, and adverse cardiovascular outcomes: cannabis may have a greater impact in non-tobacco smokers","volume":"46","author":"Winhusen","year":"2020","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"2021120111525606400_lgab012-B38","first-page":"153","article-title":"Stability of tetrahydrocannabinol and cannabidiol in prepared quality control edible brownies","volume":"41","author":"Wolf","year":"2017","journal-title":"J Anal Toxicol"},{"issue":"1","key":"2021120111525606400_lgab012-B39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.japh.2019.11.007","article-title":"Pharmacists and the future of cannabis medicine","volume":"60","author":"Schmitz","year":"2020","journal-title":"J Am Pharm Assoc"},{"issue":"4","key":"2021120111525606400_lgab012-B40","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1017\/S1092852900020757","article-title":"Delirium following ingestion of marijuana present in chocolate cookies","volume":"11","author":"Andre","year":"2006","journal-title":"CNS Spectr"},{"issue":"11","key":"2021120111525606400_lgab012-B41","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1056\/NEJMc1907013","article-title":"Medical marijuana miscalculation","volume":"381","author":"Mudan","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"2021120111525606400_lgab012-B42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2190\/DE.38.3.f","article-title":"The use of fry (embalming fluid and PCP-laced cigarettes or marijuana sticks) among crack cocaine smokers","volume":"38","author":"Peters","year":"2008","journal-title":"J Drug Educ"},{"issue":"4","key":"2021120111525606400_lgab012-B43","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/jcph.1557","article-title":"A review of cannabis and interactions with anticoagulant and antiplatelet agents","volume":"60","author":"Greger","year":"2020","journal-title":"J Clin Pharmacol"},{"issue":"10","key":"2021120111525606400_lgab012-B44","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/ajt.15398","article-title":"Evidence of a clinically significant drug-drug interaction between cannabidiol and tacrolimus","volume":"19","author":"Leino","year":"2019","journal-title":"Am J Transplant"},{"issue":"5","key":"2021120111525606400_lgab012-B45","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00406-019-01091-0","article-title":"Buprenorphine-cannabis interaction in patients undergoing opioid maintenance therapy","volume":"271","author":"Vierke","year":"2021","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"4","key":"2021120111525606400_lgab012-B46","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1634\/theoncologist.2018-0383","article-title":"Cannabis impacts tumor response rate to nivolumab in patients with advanced malignancies","volume":"24","author":"Taha","year":"2019","journal-title":"Oncologist"},{"issue":"6","key":"2021120111525606400_lgab012-B47","first-page":"571","article-title":"Cannabis hyperemesis syndrome: an update on the pathophysiology and management","volume":"33","author":"Perisetti","year":"2020","journal-title":"Ann Gastroenterol"},{"issue":"36","key":"2021120111525606400_lgab012-B48","first-page":"787","article-title":"Severe pulmonary disease was associated with electronic-cigarette product use","volume":"68","author":"Schier","year":"2019","journal-title":"CDC"},{"issue":"4","key":"2021120111525606400_lgab012-B49","doi-asserted-by":"crossref","first-page":"e202187","DOI":"10.1001\/jamanetworkopen.2020.2187","article-title":"Association of state marijuana legalization policies for medical and recreational use with vaping-associated lung disease","volume":"3","author":"Wing","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"2","key":"2021120111525606400_lgab012-B50","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/injuryprev-2019-043360","article-title":"Marijuana exposures in Colorado, reported to regional poison centre, 2000-2018","volume":"26","author":"Wang","year":"2020","journal-title":"Inj Prev"},{"issue":"4","key":"2021120111525606400_lgab012-B51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/2165079915581983","article-title":"Marijuana in the workplace: guidance for occupational health professionals and employers: joint guidance statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine","volume":"63","author":"Phillips","year":"2015","journal-title":"Workplace Health Saf"},{"key":"2021120111525606400_lgab012-B52","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drugalcdep.2018.11.016","article-title":"Driving under the influence of cannabis among medical cannabis patients with chronic pain","volume":"195","author":"Bonar","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"2021120111525606400_lgab012-B53","first-page":"S74","article-title":"Impact of trained oncology financial navigators on patient out-of-pocket spending","volume":"24","author":"Yezefski","year":"2018","journal-title":"Am J Manag Care"},{"issue":"9","key":"2021120111525606400_lgab012-B54","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1002\/cam4.1671","article-title":"Financial burden among older, long-term cancer survivors: results from the LILAC study","volume":"7","author":"Hastert","year":"2018","journal-title":"Cancer Med"},{"issue":"2","key":"2021120111525606400_lgab012-B55","doi-asserted-by":"crossref","first-page":"djw205","DOI":"10.1093\/jnci\/djw205","article-title":"Financial hardships experienced by cancer survivors: a systematic review","volume":"109","author":"Altice","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"36","key":"2021120111525606400_lgab012-B56","first-page":"787","article-title":"Severe pulmonary disease associated with electronic-cigarette- product use - interim guidance","volume":"68","author":"November","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"2021120111525606400_lgab012-B57","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/COC.0000000000000718","article-title":"Medical cannabis in cancer patients: a survey of a community hematology oncology population","volume":"43","author":"Macari","year":"2020","journal-title":"Am J Clin Oncol"},{"key":"2021120111525606400_lgab012-B58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2006.02.001","article-title":"Cannabinoids in medicine: a review of their therapeutic potential","volume":"105(1-2","author":"Benamar","year":"2006","journal-title":"J Ethnopharmacol"},{"issue":"7303","key":"2021120111525606400_lgab012-B59","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/bmj.323.7303.16","article-title":"Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review","volume":"323","author":"Tram\u00e8r","year":"2001","journal-title":"BMJ"},{"key":"2021120111525606400_lgab012-B60","first-page":"CD009464","article-title":"Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy","volume":"11","author":"Smith","year":"2015","journal-title":"Cochrane Database of Syst Rev"},{"issue":"5","key":"2021120111525606400_lgab012-B61","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00520-019-05280-4","article-title":"Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting\u2014a systematic review and meta-analysis","volume":"28","author":"Chow","year":"2020","journal-title":"Support Care Cancer"},{"issue":"4","key":"2021120111525606400_lgab012-B62","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ptr.5975","article-title":"Cannabinoids for nausea and vomiting related to chemotherapy: overview of systematic reviews","volume":"32","author":"Schussel","year":"2018","journal-title":"Phyother Res"},{"issue":"1","key":"2021120111525606400_lgab012-B63","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00482-015-0092-3","article-title":"Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting\u2014a systematic review of systematic reviews","volume":"30","author":"Tafelski","year":"2016","journal-title":"Schmerz"},{"issue":"5","key":"2021120111525606400_lgab012-B64","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1365-2125.2010.03743.x","article-title":"Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting","volume":"70","author":"Duran","year":"2010","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"2021120111525606400_lgab012-B65","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.annonc.2020.07.020","article-title":"Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial","volume":"31","author":"Grimison","year":"2020","journal-title":"Ann Oncol"},{"issue":"11","key":"2021120111525606400_lgab012-B66","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1007\/s10620-020-06195-5","article-title":"Ondansetron, and promethazine are perceived as most effective treatments for gastrointestinal nausea","volume":"65","author":"Zikos","year":"2020","journal-title":"Digest Dis Sci"},{"issue":"24","key":"2021120111525606400_lgab012-B67","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1200\/JCO.20.01296","article-title":"Antiemetics: ASCO guideline update","volume":"38","author":"Hesketh","year":"2020","journal-title":"J Clin Oncol"},{"issue":"2","key":"2021120111525606400_lgab012-B68","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1200\/JCO.2002.20.2.567","article-title":"Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study","volume":"20","author":"Jatoi","year":"2002","journal-title":"J Clin Oncol"},{"issue":"9","key":"2021120111525606400_lgab012-B69","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1093\/annonc\/mdq727","article-title":"Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial","volume":"22","author":"Brisbois","year":"2011","journal-title":"Ann Oncol"},{"issue":"9","key":"2021120111525606400_lgab012-B70","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1007\/s00520-018-4154-9","article-title":"The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial","volume":"26","author":"Turcott","year":"2018","journal-title":"Support Care Cancer"},{"key":"2021120111525606400_lgab012-B71","first-page":"1534735419881498","article-title":"The effects of dosage-controlled cannabis capsules on cancer-related cachexia and anorexia syndrome in advanced cancer patients: pilot study","volume":"18","author":"Bar-Sela","year":"2019","journal-title":"Integr Cancer Thera"},{"key":"2021120111525606400_lgab012-B72","first-page":"1","article-title":"Therapeutic satisfaction and subjective effects of different strains of pharmaceutical-grade cannabis","volume":"3","author":"Brunt","year":"2014","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"2021120111525606400_lgab012-B73","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1038\/s41598-019-39462-1","article-title":"The association between cannabis product characteristics and symptom relief","volume":"9","author":"Stith","year":"2019","journal-title":"Sci Rep"},{"issue":"12","key":"2021120111525606400_lgab012-B74","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jpain.2015.07.009","article-title":"Inhaled cannabis for chronic neuropathic pain: a meta- analysis of individual patient data","volume":"16","author":"Andreae","year":"2015","journal-title":"J Pain"},{"issue":"1","key":"2021120111525606400_lgab012-B75","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpainsymman.2013.02.018","article-title":"A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain","volume":"47","author":"Lynch","year":"2014","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"2021120111525606400_lgab012-B76","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/bmjspcare-2019-002032","article-title":"Cannabinoids for adult cancer-related pain: systematic review and meta-analysis","volume":"10","author":"Boland","year":"2020","journal-title":"BMJ Support Palliat Care"},{"issue":"6","key":"2021120111525606400_lgab012-B77","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/clpt.2011.188","article-title":"Cannabinoid-opioid interaction in chronic pain","volume":"90","author":"Abrams","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"2021120111525606400_lgab012-B78","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejim.2018.01.023","article-title":"Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer","volume":"49","author":"Bar-Lev Schleider","year":"2018","journal-title":"Eur J Intern Med"},{"issue":"1","key":"2021120111525606400_lgab012-B79","first-page":"e3918","article-title":"False news of a cannabis cancer cure","volume":"11","author":"Shi","year":"2019","journal-title":". Cureus"},{"issue":"4","key":"2021120111525606400_lgab012-B80","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00381-011-1410-4","article-title":"Spontaneous regression of septum pellucidum\/forniceal pilocytic astrocytomas\u2014possible role of cannabis inhalation","volume":"27","author":"Foroughi","year":"2011","journal-title":"Childs Nerv Syst"},{"issue":"3","key":"2021120111525606400_lgab012-B81","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1159\/000356446","article-title":"Cannabis extract treatment for terminal acute lymphoblastic leukemia with a Philadelphia chromosome mutation","volume":"6","author":"Singh","year":"2013","journal-title":"Case Rep Oncol"},{"issue":"5","key":"2021120111525606400_lgab012-B82","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jpainsymman.2017.06.005","article-title":"Topical medical cannabis: a new treatment for wound pain\u2014three cases of Pyoderma Gangrenosum","volume":"54","author":"Maida","year":"2017","journal-title":"J Pain Symptom Manage"},{"key":"2021120111525606400_lgab012-B83","first-page":"2050313X19832160","article-title":"Striking lung cancer response to self-administration of cannabidiol: a case report and literature review","volume":"7","author":"Sul\u00e9-Suso","year":"2019","journal-title":"SAGE Open Med Case Rep"},{"key":"2021120111525606400_lgab012-B84","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3389\/fonc.2018.00643","article-title":"Case report: clinical outcome and image response of two patients with secondary high-grade glioma treated with chemoradiation, PCV, and cannabidiol","volume":"8","author":"Dall\u2019Stella","year":"2019","journal-title":"Front Oncol"},{"issue":"10","key":"2021120111525606400_lgab012-B85","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.21873\/anticanres.13783","article-title":"Concomitant treatment of malignant brain tumours with CBD \u2013 a case series and review of the literature","volume":"39","author":"Likar","year":"2019","journal-title":"Anticancer Res"},{"issue":"10","key":"2021120111525606400_lgab012-B86","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.21873\/anticanres.12924","article-title":"Report of objective clinical responses of cancer patients to pharmaceutical-grade synthetic cannabidiol","volume":"38","author":"Kenyon","year":"2018","journal-title":"Anticancer Res"},{"issue":"2","key":"2021120111525606400_lgab012-B87","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.bjc.6603236","article-title":"A pilot clinical study of \u03949-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme","volume":"95","author":"Guzm\u00e1n","year":"2006","journal-title":"Br J Cancer"},{"issue":"1","key":"2021120111525606400_lgab012-B88","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1158\/1535-7163.MCT-09-0407","article-title":"Cannabidiol enhances the inhibitory effects of delta9- tetrahydrocannabinol on human glioblastoma cell proliferation and survival","volume":"9","author":"Marcu","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"2021120111525606400_lgab012-B89","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3389\/fphar.2016.00361","article-title":"Preclinical and clinical assessment of cannabinoids as anti-cancer agents","volume":"7","author":"Ladin","year":"2016","journal-title":"Front Pharmacol"},{"issue":"41","key":"2021120111525606400_lgab012-B90","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.18632\/oncotarget.26983","article-title":"The heterogeneity and complexity of cannabis extracts as antitumor agents","volume":"10","author":"Baram","year":"2019","journal-title":"Oncotarget"},{"key":"2021120111525606400_lgab012-B91","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jval.2019.05.005","article-title":"Cannabis and health research: rapid progress requires innovative research designs","volume":"22","author":"Hutchison","year":"2019","journal-title":"Value Health"}],"container-title":["JNCI Monographs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jncimono\/article-pdf\/2021\/58\/68\/41409126\/lgab012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jncimono\/article-pdf\/2021\/58\/68\/41409126\/lgab012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T01:05:24Z","timestamp":1725757524000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jncimono\/article\/2021\/58\/68\/6446214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,27]]},"references-count":91,"journal-issue":{"issue":"58","published-online":{"date-parts":[[2021,11,27]]},"published-print":{"date-parts":[[2021,11,28]]}},"URL":"https:\/\/doi.org\/10.1093\/jncimonographs\/lgab012","relation":{},"ISSN":["1052-6773","1745-6614"],"issn-type":[{"value":"1052-6773","type":"print"},{"value":"1745-6614","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,11,27]]}}}